Taking up Cancer Immunotherapy Challenges: Bispecific Antibodies, the Path Forward?
Del Bano J, Chames P, Baty D, Kerfelec B
Daniel Baty
Directeur de Recherche CNRS (DR1) Equipe
Publications
Nanobody-CD16 Catch Bond Reveals NK Cell Mechanosensitivity.
González C, Chames P, Kerfelec B, Baty D, Robert P, Limozin L
A Bispecific Antibody-Based Approach for Targeting Mesothelin in Triple Negative Breast Cancer.
Del Bano J, Florès-Florès R, Josselin E, Goubard A, Ganier L, Castellano R, Chames P, Baty D, Kerfelec B